What is the Future of HDAC Inhibitors in Pediatrics?
The future of HDAC inhibitors in pediatrics looks promising but requires more rigorous clinical trials to establish their safety and efficacy. Researchers are also exploring combination therapies that pair HDAC inhibitors with other drugs to enhance therapeutic outcomes. Personalized medicine approaches, where treatment is tailored based on the genetic and epigenetic profile of the patient, are also being considered to maximize the benefits and minimize the risks of HDAC inhibitor therapy.
